Generation of an induced pluripotent stem cell line BIOi004-A from a patient with autosomal dominant retinitis pigmentosa.

Stem Cell Res

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, Beijing, China. Electronic address:

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

RP33 is a form of autosomal dominant retinitis pigmentosa (adRP), which is caused by heterozygous variants in the SNRNP200 gene. Peripheral blood mononuclear cells (PBMCs) were isolated from a 31-year-old Chinese patient with a heterozygous c.2359G > A variant in the SNRNP200 gene. PBMCs were reprogrammed into an induced pluripotent stem cell (iPSC) line BIOi004-A. The established iPSC line had normal karyotype, expressed undifferentiated stem cell markers, and was capable to differentiate into the three germ layers in vivo.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2025.103738DOI Listing

Publication Analysis

Top Keywords

stem cell
12
induced pluripotent
8
pluripotent stem
8
autosomal dominant
8
dominant retinitis
8
retinitis pigmentosa
8
snrnp200 gene
8
generation induced
4
cell bioi004-a
4
bioi004-a patient
4

Similar Publications

Background: Active vitamin D metabolites, including 25-hydroxyvitamin D (25D) and 1,25-dihydroxyvitamin D (1,25D), have potent immunomodulatory effects that attenuate acute kidney injury (AKI) in animal models.

Methods: We conducted a phase 2, randomized, double-blind, multiple-dose, 3-arm clinical trial comparing oral calcifediol (25D), calcitriol (1,25D), and placebo among 150 critically ill adult patients at high-risk of moderate-to-severe AKI. The primary endpoint was a hierarchical composite of death, kidney replacement therapy (KRT), and kidney injury (baseline-adjusted mean change in serum creatinine), each assessed within 7 days following enrollment using a rank-based procedure.

View Article and Find Full Text PDF

Recessive TMEM167A variants cause neonatal diabetes, microcephaly and epilepsy syndrome.

J Clin Invest

September 2025

Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.

Understanding the genetic causes of diseases affecting pancreatic β cells and neurons can give insights into pathways essential for both cell types. Microcephaly, epilepsy and diabetes syndrome (MEDS) is a congenital disorder with two known aetiological genes, IER3IP1 and YIPF5. Both genes encode proteins involved in endoplasmic reticulum (ER) to Golgi trafficking.

View Article and Find Full Text PDF

Neural stem cells (NSCs) are multipotent stem cells with self-renewal capacity, able to differentiate into all neural lineages of the central nervous system, including neurons, oligodendrocytes, and astrocytes; thus, their proliferation and differentiation are essential for embryonic neurodevelopment and adult brain homoeostasis. Dysregulation in these processes is implicated in neurological disorders, highlighting the need to elucidate how NSCs proliferate and differentiate to clarify the mechanisms of neurogenesis and uncover potential therapeutic targets. MicroRNAs (miRNAs) are small, post-transcriptional regulators of gene expression involved in many aspects of nervous system development and function.

View Article and Find Full Text PDF

Engineering functional exosomes represents a cutting-edge approach in biomedicine, holding the promise to transform targeted therapy. However, challenges such as achieving consistent modification and scalability have limited their wider adoption. Herein, we introduce a universal and effective strategy for engineering multifunctional exosomes through cell fusion.

View Article and Find Full Text PDF

Retinal ganglion cells (RGCs) are highly compartmentalized neurons whose long axons serve as the sole connection between the eye and the brain. In both injury and disease, RGC degeneration occurs in a similarly compartmentalized manner, with distinct molecular and cellular responses in the axonal and somatodendritic regions. The goal of this study was to establish a microfluidic-based platform to investigate RGC compartmentalization in both health and disease states.

View Article and Find Full Text PDF